(Q36055223)

English

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen (English)

1 reference

Europe PubMed Central

11 August 2017

Robert Peter Gale

16

object named as

Robert Peter Gale

1 reference

Europe PubMed Central

11 August 2017

34

object named as

Gérard Socié

1 reference

Europe PubMed Central

11 August 2017

Hillard M. Lazarus

22

object named as

Hillard M Lazarus

1 reference

Europe PubMed Central

11 August 2017

David G. Maloney

23

object named as

David G Maloney

1 reference

Europe PubMed Central

11 August 2017

28

object named as

David A Rizzieri

1 reference

Europe PubMed Central

11 August 2017

32

object named as

Harry C Schouten

1 reference

Europe PubMed Central

11 August 2017

Mary E D Flowers

3

object named as

Mary E Flowers

1 reference

Europe PubMed Central

11 August 2017

Steven Z. Pavletic

2

object named as

Steven Z Pavletic

1 reference

Europe PubMed Central

11 August 2017

David J. Inwards-Breland

21

object named as

David J Inwards

1 reference

Europe PubMed Central

11 August 2017

7

object named as

Silvia Montoto

1 reference

Europe PubMed Central

11 August 2017

Jeanette Carreras

6

object named as

Jeanette Carreras

1 reference

Europe PubMed Central

11 August 2017

Christopher N Bredeson

11

object named as

Christopher N Bredeson

1 reference

Europe PubMed Central

11 August 2017

33

object named as

Sonali M Smith

1 reference

Europe PubMed Central

11 August 2017

18

object named as

Mehdi Hamadani

1 reference

Europe PubMed Central

11 August 2017

37

object named as

Wael Saber

1 reference

Europe PubMed Central

11 August 2017

31

object named as

Bipin N Savani

1 reference

Europe PubMed Central

11 August 2017

35

object named as

Baldeep Wirk

1 reference

Europe PubMed Central

11 August 2017

Reinhold Munker

25

object named as

Reinhold Munker

1 reference

Europe PubMed Central

11 August 2017

14

object named as

César O Freytes

1 reference

Europe PubMed Central

11 August 2017

Miguel-Angel Perales

8

object named as

Miguel-Angel Perales

1 reference

Europe PubMed Central

11 August 2017

30

object named as

Ayman Saad

1 reference

Europe PubMed Central

11 August 2017

Taiga Nishihori

26

object named as

Taiga Nishihori

1 reference

Europe PubMed Central

11 August 2017

10

object named as

Görgün Akpek

1 reference

Europe PubMed Central

11 August 2017

9

object named as

Mahmoud D Aljurf

1 reference

Europe PubMed Central

11 August 2017

Álvaro Urbano-Ispizua

1

object named as

Alvaro Urbano-Ispizua

1 reference

Europe PubMed Central

11 August 2017

4

object named as

John P Klein

1 reference

Europe PubMed Central

11 August 2017

Henry Ka-Fung Mak

15

object named as

Henry C Fung

1 reference

Europe PubMed Central

11 August 2017

Yoshihiro Inamoto

20

object named as

Yoshihiro Inamoto

1 reference

Europe PubMed Central

11 August 2017

29

object named as

Ran Reshef

1 reference

Europe PubMed Central

11 August 2017

author name string

Mei-Jie Zhang

5

1 reference

Europe PubMed Central

11 August 2017

Luciano J Costa

12

1 reference

Europe PubMed Central

11 August 2017

Christopher Dandoy

13

1 reference

Europe PubMed Central

11 August 2017

John Gibson

17

1 reference

Europe PubMed Central

11 August 2017

Robert J Hayashi

19

1 reference

Europe PubMed Central

11 August 2017

Rodrigo Martino

24

1 reference

Europe PubMed Central

11 August 2017

Richard F Olsson

27

1 reference

Europe PubMed Central

11 August 2017

Lolie C Yu

36

1 reference

Europe PubMed Central

11 August 2017

publication date

14 May 2015

1 reference

Europe PubMed Central

11 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

11 August 2017

21

1 reference

Europe PubMed Central

11 August 2017

10

1 reference

Europe PubMed Central

11 August 2017

1746-1753

1 reference

Europe PubMed Central

11 August 2017

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Allogeneic transplantation for lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Defining the intensity of conditioning regimens: working definitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

2 October 2017

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

11 July 2018

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4568162

23 September 2018

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25981509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

1 reference

https://pubmed.ncbi.nlm.nih.gov/25981509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25981509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Reg

1 reference

https://pubmed.ncbi.nlm.nih.gov/25981509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2015.05.010

1 reference

Europe PubMed Central

11 August 2017

release_wc77hlpsjvaxfc6abvtxv6tal4

1 reference

https://api.fatcat.wiki/v0/release/wc77hlpsjvaxfc6abvtxv6tal4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36055223&oldid=1989864694"